New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
13:39 EDTIARTIntegra LifeSciences deal could drive revenue growth, says Argus
Argus believes that Integra’s new three-year agreement with Premier , announced on June 12, could significantly increase the company's revenue growth in the future. The firm finds the stock's valuation attractive and keeps a Buy rating on the shares.
News For IART From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
08:10 EDTIARTSeaSpine begins trading on NASDAQ
Subscribe for More Information
June 29, 2015
06:57 EDTIARTIntegra LifeSciences to host conference call
Subscribe for More Information
June 28, 2015
12:28 EDTIARTIntegra LifeSciences to acquire TEI for $312M
Integra LifeSciences, TEI Biosciences, and TEI Medical announced a definitive agreement under which Integra will acquire all of the outstanding shares of TEI Biosciences and TEI Medical for $312M cash at closing. The companies expect to complete this transaction during Q3. Preliminarily, Integra expects the acquired revenue to increase high single digits in the first full year after closing. Integra will provide further guidance, including expectations for 2015 financial performance, when it reports Q2 results in late July. "Upon closing, we expect this deal to be immediately accretive to our adjusted EBITDA and operating margins, and slightly accretive to our adjusted EPS, including the effects of any financing transactions that may close subsequent to the closing of the TEI acquisition," said Integra CFO Glenn Coleman. Integra also noted that the acquisition will expand its sales force with the addition of roughly 125 sales reps and managers.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use